All In MedTech

FDA Clearance Tracker · P960052

DERMABOND (A FORMULATION OF 2-OCTYL CYANOACRYLATE)

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Aug 26, 1998 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Aug 26, 1998

Approved (reclassified)

Time to decision

610 days

Received Dec 24, 1996. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class II

The decision

FDA number
P960052
Device name
DERMABOND (A FORMULATION OF 2-OCTYL CYANOACRYLATE)
Applicant location
Raleigh, NC
Received
Dec 24, 1996
Decided
Aug 26, 1998
Decision
Approved (reclassified)
Expedited review
Yes, flagged as expedited in FDA's record.
Supplements
11 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 878.4010

Every decision under product code MPN

FDA's approval statement

As written in FDA's record.

This device is indicated for topical application to hold closed easily approximated skin edges from surgical incisions, including punctures from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations. DermaBond(TM) may be used in conjunction with, but not in place of, subcuticular sutures.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code MPN (Tissue adhesive for the topical approximation of skin).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Closure Medical Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.